Skip to content
MARKETS / BALCAO / LDDD
BALCAO · SERVICES-HEALTH SERVICES · SMALL CAP

Longduoduo Co. Ltd. LDDD

5 fiscal years on record · USD · FY2024 reported · SEC filings only
$4.3M
▼ 42.3% YoY
$460,435
▼ 63.3% YoY
$217,990
▼ 21.2% YoY
In brief

What this company does

LONGDUODUO OWNS THE SEVEN OPERATING COMPANIES THROUGH AN INTERMEDIARY HOLDING COMPANY REGISTERED IN HONG KONG. Our operating subsidiaries, Julong, Longduoduo Health Technology, Qingguo, Rongbin, Chengheng, Tianju and Yihua, serve, for some customers, as sales agents for third-party healthcare service providers and, for other customers, as distributors of services provided by third-party healthcare service providers. The Company mainly focuses on prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. Since June of 2023, our operating subsidiaries have been primarily engaged in selling health maintenance services provided by Inner Mongolia Honghai Health Management Co., Ltd. (“Honghai”).

Written from the business description in Longduoduo Company Limited's annual report to the U.S. Securities and Exchange Commission, filed 26 September 2025. Every sentence was checked against that document before publication.

Growth
USD 4.3M
Revenue, FY2024 · full 5-year series below
Revenue $M Net income $M
FY2024 · Revenue 4.3 · Net income 0.5
2.5M5.0M-4.0M20202021202220232024
Compound annual growth
+9.6%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
12 cents
of every revenue dollar became profit
Operating margin Net margin
FY2024 · Operating 13.0% · Net 11.5%
10%20%-100%-200%20202021202220232024
ROE
FY2024 · ROE 48.8%
500%1000%1500%20202021202220232024

Each USD of equity produced 49 cents of profit this year.

Cash & shareholders
returned in FY2024 · dividends + net buybacks
Free cash flow $
FY2024 · FCF 217990.0
40000080000020202021202220232024

Total assetsUSD 2.1M
EquityUSD 1.2M
CashUSD 1.6M
Current ratio2.18×

Equity funds 56% of total assets.

The 5-year record
5 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20242023202220212020
Revenue $B0.00.00.00.00.0
Operating income $B0.00.00.0−0.0−0.0
EBITDA $B0.00.00.0−0.0−0.0
Income tax $B0.00.00.00.0·
Net income $B0.00.0−0.0−0.0−0.0
Free cash flow $B0.00.00.0−0.00.0
EPS, diluted $0.010.04−0.00−0.29−0.00
Dividend / sh $·····
Payout %·····
ROE %48.81563.9···
Shares out B0.030.030.030.030.16

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 25 reconciliationsAUDITED

Reconciled in 5 of 19 fiscal years. 70 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Health Services
Listed onOTC market
Incorporated inNevada
Fiscal year endsJune 30
SEC categoryemerging growth company, smaller reporting company
Data on record since2020

Share this section

Download image